Albireo Pharma Inc
ALBO
ALBO was delisted on the 2nd of March, 2023.
19 hedge funds and large institutions have $17.3M invested in Albireo Pharma Inc in 2016 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 3 increasing their positions, 7 reducing their positions, and 7 closing their positions.
563% more capital invested
Capital invested by funds: $2.61M → $17.3M (+$14.7M)
14% less funds holding
Funds holding: 22 → 19 (-3)
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
57% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TGHSA
TPG Group Holdings (SBS) Advisors
Fort Worth,
Texas
|
+$16.1M |
| 2 |
Renaissance Technologies
New York
|
+$360K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$192K |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$25.9K |
| 5 |
Morgan Stanley
New York
|
+$9.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$374K |
| 2 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$87.3K |
| 3 |
Citadel Advisors
Miami,
Florida
|
-$20K |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$20K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$19.3K |
ALBO Hedge Fund Activity: Q4 2016 in Review
19 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Albireo Pharma Inc (ALBO) for Q4 2016, worth a combined $17.3M — up 563% from $2.61M a quarter earlier.
Sellers outnumbered buyers: 7 funds closed out of ALBO and 4 opened new positions — a net loss of 3 holders — while 7 trimmed existing stakes and 3 added.
The largest buyer was TPG Group Holdings (SBS) Advisors, opening a new position worth an estimated $16.1M. The largest seller was Vanguard Group, cutting an estimated $374K.
- 19 institutional investors held Albireo Pharma Inc (ALBO) as of Q4 2016, down from 22 in Q3 2016.
- Funds reported $17.3M of Albireo Pharma Inc stock for Q4 2016, up 563% quarter-over-quarter.
- 4 funds opened new Albireo Pharma Inc positions in Q4 2016 and 7 closed out, a net change of -3 holders.
- The largest Albireo Pharma Inc buyer in Q4 2016 was TPG Group Holdings (SBS) Advisors, an estimated $16.1M added.
- The largest Albireo Pharma Inc seller in Q4 2016 was Vanguard Group, an estimated $374K sold.
Based on aggregated 13F filings for Q4 2016.